Trial intelligence / Profile preview

Midazolam Levels in Follicular Fluid and IVF Outcomes

NCT03049293Phase 1Terminated

Sponsor
ART Fertility Clinics
Start
Jun 2017
Primary completion
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 1 trial of midazolam in infertility (2 arms), sponsored by ART Fertility Clinics. Primary endpoint: Midazolam values measured by the time from the injection of Midazolam to the oocyte aspiration. Started Jun 2017; status: terminated.

02

Drugs

midazolam
03

Conditions

infertility

Beyond the preview

Go deeper on NCT03049293.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03049293.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call